- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06077513
Ti-Mesh Frame Comparison for Alveolar Bone Augmentation
Human Alveolar Bone Augmentation: Comparison 3-D CAD-CAM Ti-mesh Frame With a Conventional Ti-Mesh Frame Fabricated at Time of Surgery
This research compares a chairside Titanium Mesh frame fabrication used during bone grafting procedures with the use of a computer-aided design/computer-assisted manufacture (CAD-CAM) Titanium Mesh frame. In addition, a novel method of measuring soft tissue thickness will be tested using an Optical scanner at various times during the sequence of surgeries.
The device used for shaping is a very thin, perforated titanium metal sheet with numerous small perforations (referred to as Micromesh). The construction of this device is usually accomplished chairside at the time of the surgery with custom cutting and shaping done using cues from the geometry of the surgical defect. An alternative approach will be tested where the mesh is pre-designed using digital information provided by a special xray and an optical scan device which takes a digital impression of the tooth and soft tissue surface. A digitally designed frame can then be printed using CAD-CAM software prior to surgery. This should reduce surgical time.
A randomized control trial of 30 patients needing 3-D bone augmentation will be conducted comparing chairside fabrication of Ti-MESH or TEST- CAD-CAM designed and preprinted Ti-MESH to investigate these objectives:
- Compare the operative times required for placement and removal of two different Ti-MESH frame fabrications
- Compare post-op wound healing -Ti MESH exposure rates, bone production (volume, contour, and quality) and soft tissue thickness changes during the 1-year study period.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- BU Goldman School of Dental Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Partially edentulous
- Adult dental patients that require moderate 3-D bone augmentation for dental implant site improvement
Exclusion Criteria:
- Poor oral hygiene indices for microbial plaque (PI) and gingival inflammation (GI)
- Patients who have been on Chemotherapy or Radiation therapy within last 5 years.
- Patients under active treatment with following medications: Bisphosphonates, Gabapentin, Glucocorticoids, Methotrexate, or Estrogen supplements.
- Subjects under the direct supervision of the PI
- Smoking more than 10 cigarettes per day
- Uncontrolled diabetes or other metabolic disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: CAD-CAM Ti-Mesh frame
Participants randomized into this arm will have their tooth loss treated with CAD-CAM designed and preprinted Ti-MESH during surgery.
|
CAD-CAM technology which is the process of designing and manufacturing a custom-made dental device, or a patient-specific dental device from an industrialized product, with the aid of a computer.will
be used to plan and preprint a 3-D Ti-Mesh frame prior to the surgery.
|
|
Active Comparator: Conventional Ti-Mesh frame
Participants randomized into this arm will have their tooth loss treated with conventional chairside fabrication of Ti-MESH during surgery.
|
A three-dimensional frame or cage of Ti-Mesh or Ti-reinforced d-polytetrafluoroethylene (PTFE) will be fashioned during the surgery to contain, shape and stabilize the bone graft materials (the internal scaffold).
This 3-D frame will be custom fabricated from a perforated Ti Mesh sheet material at the time of surgery which takes considerable time and skill.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bone contour accuracy
Time Frame: 5 months post op
|
Bone contour accuracy will be derived by merger of the post op Cone beam computed tomography (CBCT) DICOM file with the CBCT-1/CEREC-1/Virtual Implant file produced at the planning stage.
Accuracy of fit will be calculated for volume and linear measures (4 sides of each implant-MDBL) horizontal and vertical from the implant restorative platform.
|
5 months post op
|
|
Total surgical time
Time Frame: 2 hours
|
Total surgical time is defined as from incision time to completion of sutures and will be measured in minutes.
|
2 hours
|
|
Surgical exposure time for recipient site
Time Frame: 5 minutes
|
Surgical exposure time will be measured for recipient site in minutes
|
5 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Ti-Mesh exposure incidence
Time Frame: 1 week, 2 weeks, 4weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks
|
Number of exposures
|
1 week, 2 weeks, 4weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks
|
|
Ti-Mesh exposure size
Time Frame: 1 week, 2 weeks, 4weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks
|
Ti-Mesh exposure size will be measured in millimeters
|
1 week, 2 weeks, 4weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks
|
|
Ti-Mesh exposure location
Time Frame: 1 week, 2 weeks, 4weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks
|
Ti-Mesh exposure location will be documented within mucosa, gingiva, or at the incision line
|
1 week, 2 weeks, 4weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks
|
|
Percentage of Vital bone
Time Frame: 6 months
|
Percentage of vital bone will be measured in histologic sections of bone core taken at time of implant surgery.
|
6 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Serge Dibart, DMD, BU Goldman School of Dental Medicine, Oral Biology/Periodontics
- Study Director: Albert M Price, DMD, BU Goldman School of Dental Medicine, Oral Biology/Periodontics
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-43856
- AP 37 (Other Identifier: Geistlich Pharma North America Inc)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tooth Loss
-
Erasmus Medical CenterUniversity Medical Center Groningen; University of Santiago de CompostelaRecruitingTooth Loss / RehabilitationNetherlands
-
Institut Straumann AGCompleted
-
University of BelgradeInstitute Straumann AG, Basel, SwitzerlandActive, not recruitingTooth Loss / Rehabilitation | MaxillaSerbia
-
Murad AlrashidiNot yet recruitingSpace Maintenance | Tooth Loss / RehabilitationSaudi Arabia
-
University of AarhusCompleted
-
University of GuarulhosCompletedTooth Decay | Tooth Loss / Rehabilitation | Caries Active
-
Universidad Complutense de MadridRecruitingPartial Edentulism | Tooth Loss / RehabilitationSpain
-
Duygu KarasanHacettepe UniversityCompleted
-
Cairo UniversityNot yet recruitingLoss of Teeth Due to ExtractionEgypt
-
Eisenhower Army Medical CenterUnknownLoss of Teeth Due to ExtractionUnited States
Clinical Trials on CAD-CAM designed and preprinted Ti-Mesh frame
-
University of MilanUnknown